Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
Icelandair, Iceland’s flag carrier airline, got approval on Friday from the European Economic Area’s watchdog for a state loan guarantee, paving the way for it to raise $247m-equivalent of loan and equity financing. -
Antengene Corp, a clinical stage biopharmaceutical company, has set the ball rolling for a Hong Kong IPO, adding to a bulging pipeline of healthcare firms targeting the city’s bourse.
-
Bond investors said Argentina’s formal approach to the International Monetary Fund this week was a positive, if expected, development, but that it was still very uncertain whether the government would keep to a moderate path.
-
The Federal Reserve announced on Thursday that it will allow inflation to run higher than the long running 2% target, a long awaited and historic shift in monetary policy that marks the start of a new era that will enable the Fed to keep rates low for longer.
-
Thomas Hugger has more than two decades of investment experience in frontier markets. Volatility is part of the job description. But he has never faced challenges like those unleashed by the Covid-19 pandemic.
-
UK shopping centre owner Intu Properties has fallen into administration, throwing into question the fate of £2.5bn of CMBS notes secured by its real estate.
